Macrocycles occupy a unique segment of drug-relevant chemical space, yet they are relatively underexplored compared to acyclic small molecules. They represent a privileged class of molecules for the modulation of protein-protein interactions, and interest in macrocyclic peptides as a class has been growing in both academic and industrial circles. Natural compounds have been the main source of macrocycles with relevance for therapeutic purposes.